Agilent Technologies and Ameritox Form Collaboration, Aim to Advance Analysis of Medication Monitoring
11 Feb 2013Product news
Agilent Technologies Inc. and Ameritox today announced that they have formed a research collaboration that could accelerate analysis in the field of medication monitoring.
“By using multiple Rapid Fire systems Ameritox is streamlining the analysis of small panels of exogenous compounds compared to traditional methods of analysis,” said Can Ozbal, director of Agilent’s Rapid Fire business.
While Agilent’s RapidFire system has been used extensively in pharmaceutical and biopharmaceutical laboratories, this research collaboration with Ameritox is one of the first for Agilent’s RapidFire team in the field of medication monitoring.
“By working together and sharing moment-by-moment laboratory activity, this research arrangement gives both Ameritox and Agilent a vantage point from which we can continue to discover new uses for our science and technology,” said Jay Zimmerman, chief laboratory officer of Ameritox.
“The marriage of Agilent’s technology and Ameritox’s proprietary science could hold the key to major advancements in the field of medication monitoring,” Zimmerman said.
Related products
Request Quote for All Products
RapidFire Analysis of Clinical Research Samples
A Multiplexed Panel in The RapidFire High-throughput MS System is widely used by laboratories for HTS and ADMET programs because it enables labs to minimize staff resources and speed up turnaround time. However, RapidFire is also a promising tool for forensic toxicology and other clinical research programs to analyze blood, plasma, urine, food, and pesticides. For example, a recent clinical research application note describes how the RapidFire, as a front end to TOF MS, simultaneously multiplexed an entire panel of benzodiazepines in